Sauri Gudlavalleti is the new Chief Operating Officer of Sai Life Sciences
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
ICICI Direct gives a preview on the earnings narrative for Q3FY22
The stability is led by healthy demand in the domestic and emerging markets
The drug is priced at Rs 2000 for a course of 40 tablets
The transaction is expected to close in the first quarter of 2022
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc
The company will market it under the brand name Molflu
He has over 22 years of experience in pharmaceutical sales & business development
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
Subscribe To Our Newsletter & Stay Updated